Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00080808
What this trial is testing

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT00017576
What this trial is testing

Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00345813
What this trial is testing

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 62
Large-scale testing (Phase 3)Active Not RecruitingNCT01368588
What this trial is testing

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 2,590
Testing effectiveness (Phase 2)Study completedNCT00416533
What this trial is testing

Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 47
Testing effectiveness (Phase 2)Ended earlyNCT00003533
What this trial is testing

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Burzynski Research Institute 12
Testing effectiveness (Phase 2)WithdrawnNCT01079793
What this trial is testing

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Not applicableUnknownNCT00955435
What this trial is testing

Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15

Who this might be right for
Prostate Cancer
Cancer Trials Ireland 60
Large-scale testing (Phase 3)Study completedNCT00002597
What this trial is testing

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 2,028
Testing effectiveness (Phase 2)Study completedNCT01255891
What this trial is testing

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate

Who this might be right for
Adenocarcinoma of the Prostate
Dr. Tamim Niazi 46
Not applicableStudy completedNCT02470897
What this trial is testing

Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate Adenocarcinoma
University of Wisconsin, Madison 115
Testing effectiveness (Phase 2)Ended earlyNCT00293371
What this trial is testing

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 6
Large-scale testing (Phase 3)Study completedNCT00046943
What this trial is testing

Atrasentan in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abbott
Not applicableEnded earlyNCT00619515
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 73
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Study completedNCT00329797
What this trial is testing

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Who this might be right for
OsteoporosisProstate Cancer
Radiation Therapy Oncology Group 109
Testing effectiveness (Phase 2)Study completedNCT00003256
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Not applicableActive Not RecruitingNCT01411345
What this trial is testing

MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Miami 37
Not applicableStudy completedNCT00739791
What this trial is testing

Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 34
Testing effectiveness (Phase 2)Ended earlyNCT00459810
What this trial is testing

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 21
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation